Evaluation of arterial stiffness and serum endocan levels in patients with primary aldosteronism with new-onset hypertension and long-term hypertension-Reference-Cited by-同舟云学术

Evaluation of arterial stiffness and serum endocan levels in patients with primary aldosteronism with new-onset hypertension and long-term hypertension

Published:2022-08-03 Issue:1 Volume:46 Page:103-110
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Can M.,Kocabaş M.,Burgucu H. Ç.,Yarar Z.,Karadeniz Y.,Karaköse M.,Yerlikaya F. H.,Kulaksızoğlu M.,Karakurt F.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s40618-022-01888-2.pdf

Reference27 articles.

1. Young, Jr, WF, Kaplan NM, Rose BD (2014) Approach to the patient with hypertension and hypokalemia. UpToDate Feb 2014

2. Prejbisz A, Warchoł-Celińska E, Lenders JW, Januszewicz A (2015) Cardiovascular risk in primary hyperaldosteronism. Horm Metab Res 47(13):973–980

3. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn’s Registry. J Clin Endocrinol Metab 94:1125–1130

4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219. https://doi.org/10.1093/eurheartj/eht151

5. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al (2010) Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121:505–511. https://doi.org/10.1161/CIRCULATIONAHA.109.886655

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis;Hypertension Research;2023-08-14

2. Mineralocorticoid receptor signalling in primary aldosteronism;Journal of Endocrinology;2023-07-24

3. The Role of Endocan in Cardiometabolic Disorders;Metabolites;2023-05-08